|
[1] BRAY F,FERLAY J,SOERJOMATARAM I,et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2018,68(6):394-424.
|
|
[2] ZHOU J,SUN HC,WANG Z,et al. Guidelines for diagnosis and treatment of primary liver cancer in china(2017 edition)[J]. Liver cancer,2018,7(3):235-260.
|
|
[3] KULIK L,HEIMBACH JK,ZAIEM F,et al. Therapies for patients with hepatocellular carcinoma awaiting liver transplantation:A systematic review and meta-analysis[J]. Hepatology,2018,67(1):381-400.
|
|
[4] MARRERO JA,KULIK LM,SIRLIN CB,et al. Diagnosis,staging, and management of hepatocellular carcinoma:2018practice guidance by the American Association for the Study of Liver Diseases[J]. Hepatology,2018,68(2):723-750.
|
|
[5] RAVAIOLI M,ODALDI F,CUCCHETTI A,et al. Long term results of down-staging and liver transplantation for patients with hepatocellular carcinoma beyond the conventional criteria[J]. Sci Rep,2019,9(1):3781.
|
|
[6] PARIKH ND,WALJEE AK,SINGAL AG. Downstaging hepatocellular carcinoma:A systematic review and pooled analysis[J]. Liver Transpl,2015,21(9):1142-1152.
|
|
[7] BARAKAT O,WOOD RP,OZAKI CF,et al. Morphological features of advanced hepatocellular carcinoma as a predictor of downstaging and liver transplantation:An intention-totreat analysis[J]. Liver Transpl,2010,16(3):289-299.
|
|
[8] CESCON M,CUCCHETTI A,RAVAIOLI M,et al. Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate[J]. J Hepatol,2013,58(3):609-618.
|
|
[9] BHARAT A,BROWN DB,CRIPPIN JS,et al. Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival[J]. J Am Coll Surg,2006,203(4):411-420.
|
|
[10] YAO FY,KINKHABWALA M,LABERGE JM,et al. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma[J]. Am J Transplant,2005,5(4 Pt 1):795-804.
|
|
[11] WERNER JD,FRANGAKIS C,RUCK JM,et al. Neoadjuvant transarterial chemoembolization improves survival after liver transplant in patients with hepatocellular carcinoma[J]. Exp Clin Transplant,2019,17(5):638-643.
|
|
[12] LI HL,JI WB,ZHAO R,et al. Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation:Retrospective analysis[J]. World J Gastroenterol,2015,21(12):3599-3606.
|
|
[13] SEEHOFER D,NEBRIG M,DENECKE T,et al. Impact of neoadjuvant transarterial chemoembolization on tumor recurrence and patient survival after liver transplantation for hepatocellular carcinoma:A retrospective analysis[J]. Clin Transplant,2012,26(5):764-774.
|
|
[14] LAMMER J,MALAGARI K,VOGL T,et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma:Results of the PRECISION V study[J]. Cardiovasc Intervent Radiol,2010,33(1):41-52.
|
|
[15] FRENETTE CT,OSORIO RC,STARK J,et al. Conventional TACE and drug-eluting bead TACE as locoregional therapy before orthotopic liver transplantation:Comparison of explant pathologic response[J]. Transplantation,2014,98(7):781-787.
|
|
[16] LEE BH,LEE DS,CHO CW,et al. Role and limitation of neoadjuvant hepatic arterial infusion chemotherapy in advanced hepatocelluar carcinoma patients with Child-Pugh class A[J]. World J Surg Oncol,2019,17(1):143.
|
|
[17] LOBO L,YAKOUB D,PICADO O,et al. Unresectable hepatocellular carcinoma:Radioembolization versus chemoembolization:A systematic review and meta-analysis[J]. Cardiovasc Intervent Radiol,2016,39(11):1580-1588.
|
|
[18] SALEM R,GILBERTSEN M,BUTT Z,et al. Increased quality of life among hepatocellular carcinoma patients treated with radioembolization,compared with chemoembolization[J]. Clin Gastroenterol Hepatol,2013,11(10):1358-1365.
|
|
[19] SALEM R,GORDON AC,MOULI S,et al. Y90 radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma[J]. Gastroenterology,2016,151(6):1155-1163.
|
|
[20] LEWANDOWSKI RJ,KULIK LM,RIAZ A,et al. A comparative analysis of transarterial downstaging for hepatocellular carcinoma:Chemoembolization versus radioembolization[J]. Am J Transplant,2009,9(8):1920-1928.
|
|
[21] MOHAMED M,KATZ AW,TEJANI MA,et al. Comparison of outcomes between SBRT, yttrium-90 radioembolization,transarterial chemoembolization,and radiofrequency ablation as bridge to transplant for hepatocellular carcinoma[J]. Adv Radiat Oncol,2015,1(1):35-42.
|
|
[22] PARDO F,SANGRO B,LEE RC,et al. The Post-SIRSpheres Surgery Study(P4S):Retrospective analysis of safety following hepatic resection or transplantation in patients previously treated with selective internal radiation therapy with yttrium-90 resin microspheres[J]. Ann Surg Oncol,2017,24(9):2465-2473.
|
|
[23] GABR A,ABOUCHALEH N,ALI R,et al. Comparative study of post-transplant outcomes in hepatocellular carcinoma patients treated with chemoembolization or radioembolization[J]. Eur J Radiol,2017,93:100-106.
|
|
[24] PADIA SA,JOHNSON GE,HORTON KJ,et al. Segmental yttrium-90 radioembolization versus segmental chemoembolization for localized hepatocellular carcinoma:Results of a single-center,retrospective,propensity score-matched study[J]. J Vasc Interv Radiol,2017,28(6):777-785.
|
|
[25] BIEDERMAN DM,TITANO JJ,KORFF RA,et al. Radiation segmentectomy versus selective chemoembolization in the treatment of early-stage hepatocellular carcinoma[J]. J Vasc Interv Radiol,2018,29(1):30-37.
|
|
[26] LEWANDOWSKI RJ,DONAHUE L,CHOKECHANACHAISAKUL A,et al.(90)Y radiation lobectomy:Outcomes fol owing surgical resection in patients with hepatic tumors and small future liver remnant volumes[J]. J Surg Oncol,2016,114(1):99-105.
|
|
[27] RUDNICK SR,RUSSO MW. Liver transplantation beyond or downstaging within the Milan criteria for hepatocellular carcinoma[J]. Expert Rev Gastroenterol Hepatol,2018,12(3):265-275.
|
|
[28] KULIK L,VOUCHE M,KOPPE S,et al. Prospective randomized pilot study of Y90+/-sorafenib as bridge to transplantation in hepatocellular carcinoma[J]. J Hepatol,2014,61(2):309-317.
|
|
[29] CHOW PKH,GANDHI M,TAN SB,et al. SIRveNIB:Selective internal radiation therapy versus sorafenib in Asia-Pacific patients with hepatocellular carcinoma[J]. J Clin Oncol,2018,36(19):1913-1921.
|
|
[30] VILGRAIN V,PEREIRA H,ASSENAT E,et al. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma(SARAH):An open-label randomised controlled phase 3 trial[J]. Lancet Oncol,2017,18(12):1624-1636.
|
|
[31] KENNEDY A,BROWN DB,FEILCHENFELDT J,et al. Safety of selective internal radiation therapy(SIRT)with yttrium-90microspheres combined with systemic anticancer agents:Expert consensus[J]. J Gastrointest Oncol,2017,8(6):1079-1099.
|
|
[32] SALMAN A,SIMONEAU E,HASSANAIN M,et al. Combined sorafenib and yttrium-90 radioembolization for the treatment of advanced hepatocellular carcinoma[J]. Curr Oncol,2016,23(5):e472-e480.
|
|
[33] SHIINA S,TAGAWA K,NIWA Y,et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma:Results in 146patients[J]. AJR Am J Roentgenol,1993,160(5):1023-1028.
|
|
[34] SHIINA S,TAGAWA K,UNUMA T,et al. Percutaneous ethanol injection therapy of hepatocellular carcinoma:Analysis of77 patients[J]. AJR Am J Roentgenol,1990,155(6):1221-1226.
|
|
[35] LLOVET JM,MAS X,APONTE JJ,et al. Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation[J]. Gut,2002,50(1):123-128.
|
|
[36] POMPILI M,MIRANTE VG,RONDINARA G,et al. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation:Assessment of efficacy at explant analysis and of safety for tumor recurrence[J]. Liver Transpl,2005,11(9):1117-1126.
|
|
[37] YAO FY,HIROSE R,LABERGE JM,et al. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation[J]. Liver Transpl,2005,11(12):1505-1514.
|
|
[38] LENCIONI RA,ALLGAIER HP,CIONI D,et al. Small hepatocellular carcinoma in cirrhosis:Randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection[J]. Radiology,2003,228(1):235-240.
|
|
[39] SHIINA S,TERATANI T,OBI S,et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma[J]. Gastroenterology,2005,129(1):122-130.
|
|
[40] FENG K,YAN J,LI X,et al. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma[J]. J Hepatol,2012,57(4):794-802.
|
|
[41] FISHER RA,MALUF D,COTTERELL AH,et al. Non-resective ablation therapy for hepatocellular carcinoma:Effectiveness measured by intention-to-treat and dropout from liver transplant waiting list[J]. Clin Transplant,2004,18(5):502-512.
|
|
[42] FONTANA RJ,HAMIDULLAH H,NGHIEM H,et al. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma:A safe and effective bridge to liver transplantation[J].Liver Transpl,2002,8(12):1165-1174.
|
|
[43] MAZZAFERRO V,BATTISTON C,PERRONE S,et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation:A prospective study[J]. Ann Surg,2004,240(5):900-909.
|
|
[44] LU DS,YU NC,RAMAN SS,et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation[J]. Hepatology,2005,41(5):1130-1137.
|
|
[45] HINSHAW JL,LUBNER MG,ZIEMLEWICZ TJ,et al. Percutaneous tumor ablation tools:Microwave,radiofrequency,or cryoablation-what should you use and why?[J]. Radiographics,2014,34(5):1344-1362.
|
|
[46] POULOU LS,BOTSA E,THANOU I,et al. Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma[J]. World J Hepatol,2015,7(8):1054-1063.
|
|
[47] PILLAI K,AKHTER J,CHUA TC,et al. Heat sink effect on tumor ablation characteristics as observed in monopolar radiofrequency,bipolar radiofrequency,and microwave,using ex vivo calf liver model[J]. Medicine(Baltimore),2015,94(9):e580.
|
|
[48] SHIBATA T,IIMURO Y,YAMAMOTO Y,et al. Small hepatocellular carcinoma:Comparison of radio-frequency ablation and percutaneous microwave coagulation therapy[J]. Radiology,2002,223(2):331-337.
|
|
[49] VIETTI VIOLI N,DURAN R,GUIU B,et al. Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease:A randomised controlled phase 2 trial[J]. Lancet Gastroenterol Hepatol,2018,3(5):317-325.
|
|
[50] CHARPENTIER KP,WOLF F,NOBLE L,et al. Irreversible electroporation of the liver and liver hilum in swine[J]. HPB(Oxford),2011,13(3):168-173.
|
|
[51] PHILLIPS MA,NARAYAN R,PADATH T,et al. Irreversible electroporation on the small intestine[J]. Br J Cancer,2012,106(3):490-495.
|
|
[52] SUTTER O,CALVO J,N’KONTCHOU G,et al. Safety and efficacy of irreversible electroporation for the treatment of hepatocellular carcinoma not amenable to thermal ablation techniques:A retrospective single-center case series[J]. Radiology,2017,284(3):877-886.
|
|
[53] BHUTIANI N,PHILIPS P,SCOGGINS CR,et al. Evaluation of tolerability and efficacy of irreversible electroporation(IRE)in treatment of Child-Pugh B(7/8)hepatocellular carcinoma(HCC)[J]. HPB(Oxford),2016,18(7):593-599.
|
|
[54] WANG C,WANG H,YANG W,et al. Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma[J]. Hepatology,2015,61(5):1579-1590.
|
|
[55] WU S,HOU J,DING Y,et al. Cryoablation versus radiofrequency ablation for hepatic malignancies:A systematic review and literature-based analysis[J]. Medicine(Baltimore),2015,94(49):e2252.
|
|
[56] SEIFERT JK,MORRIS DL. World survey on the complications of hepatic and prostate cryotherapy[J]. World J Surg,1999,23(2):109-113.
|
|
[57] RONG G,BAI W,DONG Z,et al. Long-term outcomes of percutaneous cryoablation for patients with hepatocellular carcinoma within Milan criteria[J]. PLo S One,2015,10(4):e0123065.
|
|
[58] SHI F,WU M,LIAN SS,et al. Radiofrequency ablation following downstaging of hepatocellular carcinoma by using transarterial chemoembolization:Long-term outcomes[J]. Radiology,2019,293(3):707-715.
|
DownLoad: